^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

GD2-targeted CAR-T cells

i
Other names: GD2-targeted CAR-T cells, CAR-GD2-modified T cells
Associations
Company:
Sinobioway
Drug class:
GD2-targeted CAR-T immunotherapy
Associations
1m
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas. (PubMed, Mol Ther Oncol)
Here, we show that infection with Goravir adenovirus and R124 reovirus induced DMG cell lysis (n = 6 cultures), with minimal effect on the viability of B7H3- or GD2-targeted CAR T cells, even at high virus concentrations...The successful combinations exhibited enhanced cytokine and chemokine release, coupled with an increased cytotoxic phenotype. These findings highlight the benefit of DMG pre-infection with OVs to boost CAR T cell activity and suggest that immune stimulation is a key driver of enhanced combination responses.
Journal • IO biomarker
|
CD276 (CD276 Molecule)
|
GD2-targeted CAR-T cells